Working… Menu

Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002) (KCC-SMT-002)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03229798
Recruitment Status : Active, not recruiting
First Posted : July 26, 2017
Last Update Posted : April 6, 2018
Information provided by (Responsible Party):
Kimberly-Clark Corporation